Sunvozertinib(2370013-12-8)
- Name: Sunvozertinib
- Synonyms:sunvozertinib;Sunvozertinib [INN];L1Q2K5JYO8;2370013-12-8;DZD9008;UNII-L1Q2K5JYO8;2-Propenamide, N-(5-((4-((5-chloro-4-fluoro-2-(1-hydroxy-1-methylethyl)phenyl)amino)-2-pyrimidinyl)amino)-2-((3R)-3-(dimethylamino)-1-pyrrolidinyl)-4-methoxyphenyl)-;SUNVOZERTINIB [USAN];SCHEMBL21232131;GTPL11672;GLXC-25829;ASYM-122507;DZD-9008;EX-A6612;DZ0586;DZ-0586;MS-30456;Example 52 [WO2019149164A1];HY-132842;CS-0204146;DZ00000586;A-1801;2-Propenamide, N-[5-[[4-[[5-chloro-4-fluoro-2-(1-hydroxy-1- methylethyl)phenyl]amino]-2-pyrimidinyl]amino]-2-[(3R)-3-(dimethylamino)-1-pyrrolidinyl]-4-methoxyphenyl]-;N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide;N-{5-[(4-{[5-chloro-4-fluoro-2-(1-hydroxy-1-methylethyl)phenyl]amino}pyrimidin-2-yl)amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl}prop-2-enamide
- Molecular Formula:C29H35ClFN7O3
- Molecular Weight:584.1
- CAS Registry Number:2370013-12-8
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.2370013-12-8 Sunvozertinib
Assay:99% Application:api
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.2370013-12-8 Sunvozertinib;2370013-12-8
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal ChemistryBiomedicinePharmaceutical intermediatesChemistry experimentBiological experimentsChemical reagentFor R&D use only.
Min. Order:10Metric Ton
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)] CAS No.2370013-12-8 Sunvozertinib
Assay:>98% Appearance:Solid Powder Storage:Store at -20掳C Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 1245570-04-0/N1,N1-dimethylethane-1,2-diamine dihydrobromide
- 122180-16-9/(4-Methyl-2-oxo-2H-pyridin-1-yl)-acetic acid
- 914287-23-3/2-[5-(4-fluorophenyl)-2-methyl-4-imidazolylidene]-N-propan-2-yl-3H-thiazole-4-carboxamide
- 640270-01-5/4-(1-methyl-1H-pyrazol-5-yl)piperidine
- 1309602-76-3/Trimethylsilyl 2-(2-bromotetrafluoroethoxy)tetrafluoropropionate
- 176524-12-2/Ethyl 3-(4-chlorobenzyl)piperidine-3-carboxylate hydrochloride
- 1196152-92-7/1-Chloro-6-(trifluoromethyl)isoquinoline
- 1199215-91-2/Methyl 4-(4H-1,2,4-triazol-3-YL)benzoate
- 1361113-65-6/2-(Dimethylamino)-N-(2-(pyrrolidin-2-yl)ethyl)acetamide
- 1400645-27-3/1-(3-Chloro-pyrazin-2-YL)-piperidine-4-carboxylic acid methyl ester
- 17033-69-1/4-Methylbenzo[c]phenanthrene;2,4,7-trinitrofluoren-9-one
- 1240597-65-2/5-Chloro-2-cyclopropylpyrimidine-4-carboxylic acid
- 1422343-76-7/Tenofovir alafenamide monofumarate
- 664371-35-1/N-(4,6-dimethylpyrimidin-2-yl)indoline-1-carboximidamide
- 79025-39-1/2,5-Dichloro-4-methoxybenzonitrile
- 957509-32-9/2-NitrobenzaldehydeSemicarbazone-13C,15N2
- 618098-08-1/3-(4-Fluorophenyl)-1-(4-methoxyphenyl)-1H-pyrazol-5-amine
- 1160263-72-8/7-Chloro-2-(4-ethoxyphenyl)-8-methylquinoline-4-carbonyl chloride
- 1245532-88-0/3-Bromo-2-methoxy-4,5-dimethylbenzoic acid
- 2370013-12-8/Sunvozertinib
- 1262006-93-8/3-(5-Fluoro-2-methoxyphenyl)-5-trifluoromethylbenzoic acid
- 1160249-22-8/4-Bromo-3-chloro-1-benzothiophene-2-carbonyl chloride
- 2249435-90-1/N-[3-[(4-Fluorophenyl)sulfonylamino]-4-hydroxyphenyl]-4-phenylbenzamide
- 1187927-19-0/Methyl 3-amino-2-methoxybenzoate hydrochloride
- 1245648-46-7/2-Ethynyl-1-(4-methylbenzene-1-sulfonyl)-1H-pyrrolo[2,3-b]pyridine
- 1356114-70-9/N-(Piperidin-4-ylmethyl)-2-(trifluoromethyl)-1,6-naphthyridin-5-amine hydrochloride hydrate
- 1214339-48-6/4-Bromo-2-(trifluoromethyl)phenylacetic acid
- 725705-51-1/4-allyl-5-(2-ethoxyphenyl)-4H-1,2,4-triazole-3-thiol
- 898762-08-8/2-(4-Bromophenyl)ethyl cyclobutyl ketone
- 1391053-45-4/(+/-)-5-Benzoyl-1-methoxy-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid